Patricia M. Rice, MS

Vice President, Biostatistics and Data Management
Emalex Biosciences, Inc.

Poster(s):

• (62) Efficacy and safety of ecopipam for Tourette syndrome: results from a phase 3, randomized, double-blind, placebo-controlled withdrawal trial
  Wednesday, October 29, 2025